These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8542584)
1. Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A. de Groene EM; Hassing IG; Blom MJ; Seinen W; Fink-Gremmels J; Horbach GJ Cancer Res; 1996 Jan; 56(2):299-304. PubMed ID: 8542584 [TBL] [Abstract][Full Text] [Related]
2. DNA adduct formation by 7H-dibenzo[c,g]carbazole and its tissue- and organ-specific derivatives in Chinese hamster V79 cell lines stably expressing cytochrome P450 enzymes. Gábelová A; Binková B; Valovicová Z; Srám RJ Environ Mol Mutagen; 2004; 44(5):448-58. PubMed ID: 15534862 [TBL] [Abstract][Full Text] [Related]
3. Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons. Kappers WA; van Och FM; de Groene EM; Horbach GJ Mutat Res; 2000 Mar; 466(2):143-59. PubMed ID: 10727902 [TBL] [Abstract][Full Text] [Related]
4. Mutagenicity and genotoxicity of the mycotoxin ochratoxin A. de Groene EM; Jahn A; Horbach GJ; Fink-Gremmels J Environ Toxicol Pharmacol; 1996 Feb; 1(1):21-6. PubMed ID: 21781659 [TBL] [Abstract][Full Text] [Related]
5. The development of a panel of human cell lines expressing specific human cytochrome P450 cDNAs. Crespi CL; Langenbach R; Penman BW Prog Clin Biol Res; 1990; 340B():97-106. PubMed ID: 2392454 [TBL] [Abstract][Full Text] [Related]
6. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Cruzan G; Bus J; Banton M; Gingell R; Carlson G Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367 [TBL] [Abstract][Full Text] [Related]
7. A NIH/3T3 cell line stably expressing human cytochrome P450-3A4 used in combination with a lacZ' shuttle vector to study mutagenicity. De Groene EM; Seinen W; Horbach GJ Eur J Pharmacol; 1995 May; 293(1):47-53. PubMed ID: 7545582 [TBL] [Abstract][Full Text] [Related]
8. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Zepnik H; Pähler A; Schauer U; Dekant W Toxicol Sci; 2001 Jan; 59(1):59-67. PubMed ID: 11134544 [TBL] [Abstract][Full Text] [Related]
9. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs. Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391 [TBL] [Abstract][Full Text] [Related]
10. Metabolism-mediated Ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Simarro Doorten Y; Nijmeijer S; de Nijs-Tjon L; Fink-Gremmels J Food Chem Toxicol; 2006 Feb; 44(2):261-70. PubMed ID: 16139406 [TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Fang J; McKay G; Song J; Remillrd A; Li X; Midha K Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Chen L; Waxman DJ; Chen D; Kufe DW Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822 [TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
14. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161 [TBL] [Abstract][Full Text] [Related]
15. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens. Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838 [TBL] [Abstract][Full Text] [Related]
16. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Yang SP; Raner GM Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189 [TBL] [Abstract][Full Text] [Related]
18. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation. Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186 [TBL] [Abstract][Full Text] [Related]
19. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Dixon CM; Colthup PV; Serabjit-Singh CJ; Kerr BM; Boehlert CC; Park GR; Tarbit MH Drug Metab Dispos; 1995 Nov; 23(11):1225-30. PubMed ID: 8591723 [TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Arbillaga L; Azqueta A; Ezpeleta O; López de Cerain A Mutagenesis; 2007 Jan; 22(1):35-42. PubMed ID: 17130176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]